Peptide Research

THE BIG PEPTIDE SHIFT: WHAT'S CHANGING, WHAT TO EXPECT, AND WHAT IT MEANS FOR YOU 14 Peptides May Return to Legal Compounding. Here's Everything You Need to Know — In Plain English. FOR RESEARCH AND EDUCATIONAL PURPOSES ONLY This document provides educational information about emerging regulatory developments in the pept...

WHY DID PEPTIDE SCIENCES SHUT DOWN OVERNIGHT? The inside story: FDA, Big Pharma lawsuits, and the quality failures that brought down a $7.4M/month empire. Quick answer: Peptide Sciences, the largest U.S. gray-market research peptide vendor, abruptly shut down in March 2026 amid FDA scrutiny and pharmaceutical indus...

PATH TO PEPTIDES GLP-1 AND SLEEP APNEA: BREATHE EASIER, SLEEP BETTER Tirzepatide became the first-ever medication approved for obstructive sleep apnea. THE FIRST DRUG FOR SLEEP APNEA — EVER Quick answer: Tirzepatide became the first medication ever approved for obstructive sleep apnea, offering a new treatment pa...

PATH TO PEPTIDES GLP-1 AND YOUR LIVER: THE MASH BREAKTHROUGH Fatty liver disease affects 1 in 3 adults. Semaglutide just became the first GLP-1 approved to treat it. THE SILENT EPIDEMIC IN YOUR LIVER Quick answer: Semaglutide became the first GLP-1 medication approved to treat MASH (metabolic dysfunction-associat...

PATH TO PEPTIDES GLP-1 AND YOUR KIDNEYS: THE FLOW TRIAL BREAKTHROUGH Semaglutide now FDA-approved to protect kidneys. Here's what the science says. A FOURTH PILLAR OF KIDNEY PROTECTION Quick answer: The FDA approved semaglutide in January 2025 to reduce the risk of kidney disease progression, based on the FLOW tr...

PATH TO PEPTIDES THE GLP-1 PILL IS HERE: NO MORE NEEDLES? Oral Wegovy just got FDA-approved. Orforglipron is next. Welcome to the pill era. THE END OF THE NEEDLE ERA? Quick answer: The FDA approved oral Wegovy in December 2025, marking the first pill-form GLP-1 medication, with orforglipron expected to follow. Or...

PATH TO PEPTIDES ANTIMICROBIAL PEPTIDES: YOUR BODY'S NATURAL DEFENSE By 2050, antibiotic-resistant infections could kill 10 million people per year. Quick answer: Antimicrobial peptides (AMPs) are short, naturally occurring immune molecules that many organisms use as a first line of defense against bacteria, virus...

PATH TO PEPTIDES COLLAGEN PEPTIDES: WHAT SCIENCE SAYS ABOUT JOINTS, TENDONS, AND SKIN Collagen supplements are a $7 billion industry. New research shows specific peptide fragments survive digestion and reach your joints. Here's what matters. Quick answer: Collagen peptides are short chains of amino acids made by b...

PATH TO PEPTIDES: OZEMPIC FACE AND MUSCLE LOSS THE BODY COMPOSITION PROBLEM Up to 25% of weight lost on GLP-1 drugs is muscle, not fat. Why that matters — and what research says about protecting lean mass. HERE'S A NUMBER THAT SHOULD GET YOUR ATTENTION: STUDIES SHOW THAT UP TO 25% OF THE WEIGHT PEOPLE LOSE ON GLP-1 DRUGS...